Abstract-An essential role for protein kinase C ⑀ (PKC⑀) has been shown in multiple forms of cardioprotection; however, there is a distinct paucity of information concerning the signaling architecture that is responsible for the manifestation of a protective phenotype. We and others have recently shown that signal transduction may proceed via the formation of signaling complexes (Circ Res. 2001;88:59 -62 
T he protein kinase C ⑀ (PKC⑀) signaling system in cardioprotection has two conceptual components: (1) the molecules that are involved in PKC⑀ signaling and (2) the manner in which these molecules interact with PKC⑀. The first of these components has been extensively studied, [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] which has resulted in the identification of numerous signaling elements that may participate in PKC⑀-mediated preconditioning (PC). However, the latter component, that is, the specific infrastructure established by these signaling elements to engender cardioprotection, remains undefined. Evidence from recent studies in numerous cellular theaters suggests that signal transduction may proceed via the formation of multiprotein signaling complexes. [13] [14] [15] [16] [17] Our laboratory has shown that PKC⑀ forms signaling complexes with at least 36 proteins in the heart, and that PKC⑀-mediated cardioprotection is associated with dynamic modulation of these complexes. 17 Despite this, the specific manner in which PKC⑀ might interact with a member of its complex in order to perform functional signaling tasks is at present unknown.
Previous studies pertaining to the components of the signaling system in cardioprotection have implicated a role for tyrosine kinases. 8,12,18 -22 Our laboratory has reported that ischemic PC induces activation of Src in a PKC-dependent manner in conscious rabbits. 8 Mounting evidence has demonstrated that the administration of a nitric oxide (NO) donor fully mimics the delayed cardioprotective effect afforded by ischemic PC. 1, 7 Furthermore, this pharmacological PC also utilizes a PKC⑀-dependent signaling mechanism. 1, 7 However, the ability of, and the mechanism used by, NO to activate Src and to modulate the involvement of Src in NO-induced late PC in the myocardium remains to be elucidated. It was recently found in murine fibroblasts that Src could be induced to autophosphorylate and become active by NO, 23 which raises the possibility that NO may activate Src via separate, non-PKC⑀-dependent mechanisms in the heart. In rat cardiomyocytes, oxidative stress is effective in activating extracellular signal-regulated kinases (ERKs) via an Src-dependent pathway, a phenomenon which is not blocked by inhibitors of PKC and/or PKA. 23 Therefore, it is unclear whether NO can activate Src in the myocardium, and whether this occurs via activation of PKC.
Analyses of PKC⑀ signaling complexes in the murine myocardium revealed that Src, a member of the Src family of nonreceptor tyrosine kinases, resides in the PKC⑀ complex. 17 Although the individual roles of Src and PKC⑀ have been extensively studied, 2,24 -29 it remains unknown if PKC⑀ interacts with Src, and if so, whether their direct interaction promotes signal transduction, ie, whether association with PKC⑀ activates Src. The fulfillment of these criteria would indicate that PKC⑀ and Src constitute a signaling module.
Accordingly, we designed a study to comprehensively analyze the interactions of PKC⑀ and Src in NO-induced late PC. We reasoned that if signaling in NO-induced PC proceeds by the assembly of a module containing PKC⑀ and Src, then the association of Src with PKC⑀ in this fashion might lead to increased enzymatic activity of Src. To test this, we analyzed the enzymatic activity and subcellular localization of Src and the association of Src with the PKC⑀ signaling complex. The PKC inhibitor chelerythrine (CHE) was given, at a dose shown previously to block late NO-induced PC, to determine whether the formation of a PKC⑀-Src module is an essential part of the signaling architecture that protects the heart against injury. We found that NO-induced cardioprotection involves the formation of a module containing PKC⑀ and Src in the particulate fraction. Association of Src with PKC⑀ in this module dynamically enhances Src kinase activity during the late phase of protection.
Materials and Methods

Recombinant Proteins and Reagents
In vitro studies used cDNAs of wild-type PKC⑀ (rabbit), wild-type Src (mouse), and a mutant of Src, which were cloned into the pAcGHLT vector, expressed in the baculovirus system, and purified to generate glutathione S-transferase (GST) fusion proteins (Pharmingen). Cold or [
35 S]-methionine-labeled recombinant proteins of wild-type PKC⑀, wild-type Src, and a mutant of Src (Y529F) were also made through in vitro transcription and translation using the TNT Quick-Coupled reticulocyte system (Promega). The GST-PKC⑀, GST-Src, and the in vitro-translated PKC⑀ and Src were all verified to retain kinase activity (data not shown). Inhibitor sources were as follows: PKC inhibitors chelerythrine (Sigma) and GF109203X (Calbiochem); Src inhibitor PP2 (Calbiochem).
Assessing Protein-Protein Interactions Via GST Affinity Pull-Down Assays
Briefly, GST-recombinant proteins were immobilized on GST beads, mixed with either recombinant proteins of interest or rabbit myocardial homogenates, and incubated in binding buffer with various concentrations of NaCl, as previously reported. 17, 30 The GST-protein complexes were washed, resolved by SDS-PAGE, and analyzed via immunoblotting with antibodies against corresponding proteins. Parallel reactions were conducted using equal molar amounts of GST-null proteins in place of the tested GST-fusion proteins (negative control). A well-established conscious rabbit model of NO-induced PC was used as previously described. 7, 31, 32 Briefly, male New Zealand White rabbits (Myrtle's Rabbitry Inc, Thompson Station, Tenn; 2.0 to 2.5 kg, age 3 to 4 months) were intravenously administered the NO donor diethylenetriamine/NO (DETA/NO, 0.1 mg/kg once every 25 minutes for 75 minutes; total dose of 0.4 mg/kg). This dose of DETA/NO has been shown to be sufficient to trigger activation of PKC⑀ on day 1 and to protect against myocardial infarction and stunning on day 2. 7, 31, 32 To determine whether inhibition of PKC, which has been demonstrated to block NO-induced PC, would affect PKC⑀-Src signaling module formation, the PKC inhibitor chelerythrine (CHE; dose 5 mg/kg) was given 5 minutes before the first DETA/NO injection. 7, 10 This dose of CHE has been shown to abolish NO-induced activation of PKC⑀ and to abrogate NO-induced late cardioprotection. 7, 10 Rabbits in control groups received vehicle. To characterize PKC⑀-Src module formation during the temporal development of NO-induced PC, cardiac tissues were taken at two time points: (1) at 30 minutes after the last DETA/NO injection (day 1) and (2) at 24 hours after DETA/NO (day 2). Hearts were frozen and stored at Ϫ80°C. Before biochemical analysis, tissue samples were fractionated as previously reported. 6
The Conscious Rabbit
Recombinant Adenoviral-Mediated PKC⑀ Transfection in Adult Rabbit Cardiomyocytes
Recombinant adenoviruses encoding active PKC⑀ were used to produce activation of PKC⑀ in cardiomyocytes. Generation of recombinant viruses and isolation of adult cardiomyocytes were performed as detailed previously. 5, 9 Immunoprecipitation and Western Blotting PKC⑀ and Src antibody-based immunoprecipitations were performed as previously documented. 7, 8, 17, 33 IgG (Sigma) was substituted to determine nonspecific binding. Immunoblotting was performed for PKC⑀ and Src as previously described. 6, 17, 33 
PKC⑀ and Src Activity Assays
The phosphorylation activity of PKC⑀ and Src was determined as previously described. 7, 8 Briefly, cytosolic or particulate samples were immunoprecipitated overnight with either PKC⑀ (Pharmingen) or Src (Santa Cruz) antibodies. The PKC⑀ phosphorylation activity was determined by incubating immunoprecipitates with the PKC⑀-selective substrate (ERMRPRKRQGSVRRRV) in the PKC⑀ phosphorylation cocktail. 7 Src phosphorylation activity was assessed by incubating the immunoprecipitates with either the Src-selective peptide (KVEKIGEGTYGVVYK) (Upstate) or enolase (Sigma) as substrates in the Src phosphorylation cocktail. 8 The PKC⑀-associated Src phosphorylation activity was determined by subjecting the PKC⑀-immunoprecipitated complex to the Src phosphorylation assay using the peptide as a substrate.
Statistical Analysis
For ease of comparison, measurements of kinase activity or protein level in each individual experiment were expressed as a percentage of the average value for the respective control group. Differences among the experimental groups were analyzed using ANOVA. When necessary, post hoc contrasts and Student's t tests for unpaired data using Bonferroni correction were performed. 34 Data are reported as meanϮSEM.
Results
PKC⑀ and Src Form a Functional Module
Recombinant PKC⑀ and GST-Src proteins were used to determine whether PKC⑀ and Src were binding partners. GST-Src was found to interact with PKC⑀ in vitro ( Figure 1 ). The intensity of interaction between PKC⑀ and Src varied with NaCl concentration, indicating that the binding between these two molecules is ionic in nature ( Figure 1A , lanes 1 through 3). Next, we determined whether Src colocalizes with PKC⑀ in the rabbit myocardium. Western immunoblots for Src revealed that endogenous Src associated with the GST-PKC⑀ complex ( Figure 1B) . Interestingly, the association of Src with the GST-PKC⑀ complexes was found to be subcellular location-specific, as only Src from the particulate fraction, and not that from the cytosolic, interacted with the GST-PKC⑀ complex ( Figure 1B , lanes 8 and 9 and 3 and 4, respectively). To our knowledge, this is the first demonstration that PKC⑀ can bind directly to Src.
To determine whether the conformation of Src affects its binding affinity for PKC⑀, we performed GST pull-down assays using GST-PKC⑀ and in vitro-translated wild-type Src and the Y529F mutant Src, which exists in an open conformation ( Figure 1C ). GST-PKC⑀ exhibited stronger binding with the mutant Src than with wild-type Src, a phenomenon that appeared to be concentration-dependent ( Figure 1C ). These data show that when Src is in its open configuration, it displays higher binding affinity for PKC⑀.
We then proceeded to assess whether the in vitro association of PKC⑀ and Src results in the transduction of a signal, that is, whether activation of PKC⑀ enhances Src activity. Active PKC⑀ was incubated with recombinant Src and the Src-specific substrate protein enolase. Activity of Src, as assessed by its phosphorylation of enolase, was significantly higher in the presence of PKC⑀ compared with that in the absence of PKC⑀ ( Figure 1D ), indicating that PKC⑀ activates Src. To verify this result, we also performed Src phosphorylation activity assay using the Src-selective substrate peptide. 8 These data confirmed the finding that PKC⑀ induced activation of Src in vitro ( Figure 1D ).
To further characterize the interaction of PKC⑀ with Src in cardiomyocytes, we performed transfection experiments with adenoviruses encoding active PKC⑀. 5, 9 Adult rabbit cardiomyocytes receiving PKC⑀ adenoviruses exhibited activation of PKC⑀ 5, 9 and displayed a marked increase in Src kinase activity (235.8Ϯ8.8% of null vector; PϽ0.05) ( Figure 1E ). Treatment with the PKC inhibitor GF109203X blocked activation of PKC⑀ 5 as well as PKC⑀-induced activation of Src (80.4Ϯ7% of null vector). As expected, Src activation was also blocked by the Src inhibitor PP2 (91.9Ϯ9.0% of null vector). These data indicate that, in adult cardiomyocytes, PKC⑀ activation is sufficient to stimulate increased Src kinase activity.
Increased Association of Src With the PKC⑀ Complex During the Development of NO-Induced Cardioprotection
We next examined whether the association of Src with the PKC⑀ complex was concomitant with the development of cardioprotection in vivo. It has been well documented that NO-induced PC requires activation of PKC. 1, 7 Although tyrosine kinases have been implicated in PC, 8, 12, 20, 35 the manner in which Src participates in PKC⑀-dependent signaling during NO-induced PC is unknown. To address this issue, we determined whether NO-induced cardioprotective signaling involves the colocalization of Src and PKC⑀, and whether the interactions of PKC⑀ and Src correspond with the tem- poral development of NO-induced PC. Rabbits were administered DETA/NO at a dose that has been previously demonstrated to generate a late phase of cardioprotection against infarction and stunning. 1, 7, 31, 32 We found that this dose of DETA/NO promoted recruitment of Src to the PKC⑀ complex. The amount of Src protein associated with the PKC⑀ complex was significantly increased at 30 minutes (187.0Ϯ1.1% of control; PϽ0.05) and at 24 hours (286.0Ϯ3.5% of control; PϽ0.05) after DETA/NO ( Figure  2A ). These data suggest that PKC⑀-mediated signal transduction during the genesis (30 minutes) and the manifestation (24 hours) of NO-induced late PC involves an increased formation of PKC⑀-Src modules.
Assembly of PKC⑀-Src Modules Increases Src Enzymatic Activity In Vivo
In order to understand if, and the manner by which, complex formation might facilitate signal transduction in vivo, we determined the PKC⑀-associated Src kinase activity in hearts from conscious rabbits. Cardiac tissues were immunoprecipitated with PKC⑀ antibodies and subjected to Src activity assay. In hearts obtained 30 minutes after DETA/NO administration, we observed a significant increase in PKC⑀-associated Src kinase activity (181.0Ϯ0.4% of control; PϽ0.05) ( Figure 2B ). Of particular importance, in hearts obtained 24 hours after DETA/NO administration, we found a marked increase in the PKC⑀-associated Src kinase activity (1082Ϯ319.1% of control; PϽ0.05) ( Figure 2B ), a magnitude of increase far exceeding that observed at 30 minutes. Importantly, when analysis of Src activity included both the non-PKC⑀-associated Src and the PKC⑀-associated Src (30 minutes: 141.5Ϯ2.6% of control; 24 hours: 277.0Ϯ5.4% of control; PϽ0.05) (Figure 2C ), the increase in Src activity induced by NO was significantly less compared with the activity of PKC⑀-associated Src alone. The basal Src activity measurements in control animals (data not shown) were comparable to those previously reported. 8 Taken with the data shown in Figure 2B , these findings indicate that the PKC⑀-associated Src accounted for the increased activity attributed to the particulate Src and exhibited higher activity than that of the non-PKC⑀-associated Src.
These observations indicate that within the PKC⑀ complex, a module containing PKC⑀ and Src is formed, and that assembly of this module facilitates the transduction of a signal by increasing the enzymatic activity of Src.
NO-Induced Late PC Involves Increased Particulate Expression of PKC⑀ But Not Src
The subcellular alterations that could lead to increased module formation are undoubtedly extensive. However, four fundamental scenarios, designed to incorporate a range of conceivable biochemical changes that could result in increased module formation, are discussed in Figure 3 . In the present study, we measured the level of expression and activity of PKC⑀ and Src during NO-induced PC to determine which, if any, of these mechanisms might contribute to increased module formation between PKC⑀ and Src.
In agreement with our previous report, 7 we found that DETA/NO induced PKC⑀ translocation at 30 minutes after Figure 2 . PKC⑀-Src module formation enhances Src kinase activity in vivo. A, Representative immunoblot displaying PKC⑀-associated Src in the particulate fraction. Data were obtained via PKC⑀ immunoprecipitation followed by immunoblotting for Src (parallel experiments detected no PKC⑀-associated Src in the cytosolic fraction; data not shown). Graph depicts increased association of Src with the PKC⑀ complex at 30 minutes and 24 hours after DETA/NO. B, Particulate PKC⑀-associated Src activity was found to be significantly increased at 30 minutes and 24 hours after DETA/NO. Inhibition of PKC⑀ with CHE abolished PKC⑀-associated Src activity. C, When both particulate PKC⑀-associated and non-PKC⑀-associated Src were considered, the degree of increase in Src activity was markedly lower, indicating that PKC⑀-associated Src exhibited higher phosphorylation activity than did non-PKC⑀-associated Src. Figure 4A ). Moreover, we also observed significant translocation of PKC⑀ at 24 hours after NOinduced PC ( Figure 4A ). The increased particulate localization of PKC⑀ at 24 hours appeared to be partially supported by an increase of total PKC⑀ protein (196.3Ϯ20.0% of control; PϽ0.05), whereas total PKC⑀ expression was not altered at 30 minutes after DETA/NO (data not shown). Furthermore, inhibition of PKC with CHE before DETA/NO treatment abolished NO-induced translocation of PKC⑀ both at 30 minutes and at 24 hours (data not shown). CHE also abrogated the increased expression of PKC⑀ protein that was seen 24 hours later (127.1Ϯ5.0% of control).
NO-induced PC (
As shown in Figure 2B , DETA/NO induced a significant increase in the PKC⑀-associated Src activity. We next examined the effect of NO on Src protein level at 30 minutes and 24 hours after DETA/NO. Our data show that Src expression remained unaltered at either 30 minutes or 24 hours after DETA/NO administration ( Figure 4B ). Furthermore, DETA/NO did not cause a subcellular redistribution of Src kinase ( Figure 4B ), in that the expression of Src was unchanged when either the total or the particulate fraction alone was considered at both 30 minutes (total Src: 83.6Ϯ6.0% of control; particulate Src: 105.0Ϯ0.9% of control) and at 24 hours (total Src: 121.4Ϯ21.7% of control; particulate Src: 102.4Ϯ0.4% of control). Treatment with CHE before DETA/NO treatment did not alter the expression of Src in either the total or particulate pool both at 30 minutes and 24 hours after DETA/NO administration (data not shown).
CHE Inhibits PKC⑀-Src Module Formation and Blocks Cardioprotection
Previous studies have demonstrated that CHE, given at a dose that inhibits PKC⑀ activation, is sufficient to block the salubrious effects afforded by ischemic and NO-induced PC. 7, 10 In the present investigation, our data demonstrate that pretreatment with this same dose of CHE abolished DETA/ NO-induced formation of PKC⑀-Src modules both at 30 minutes (123.4Ϯ3.9% of control) and at 24 hours (75.4Ϯ0.6% of control) ( Figure 5 ). In accordance with the disruption of module formation by CHE was the observation that CHE also attenuated the NO-induced increase in PKC⑀-associated Src activity at 30 minutes (132.3Ϯ18.9% of control) and at 24 hours (95.8Ϯ10.3% of control) ( Figure  2B ). These data demonstrate that the activation of PKC by NO is a prerequisite for PKC⑀-Src module formation and function 24 hours later. Furthermore, the assembly of PKC⑀- Schematic representation of the possible stoichiometric-or affinity-based changes that may occur to elicit increased module formation between two hypothetical signaling proteins, X and Y. A module is defined as the association between two or more proteins that leads to unidirectional or bidirectional (ie, mutual) posttranslational modification (eg, phosphorylation) and that results in signal transduction. We envision that a signaling complex may contain multiple modules. 36 To investigate the observation that cardioprotection (along with other cellular phenomena) has been associated with dynamic regulation of multiprotein complexes, four plausible mechanisms were conceptualized that could theoretically lead to an increase in module assembly between X and Y. A, Enhanced affinity of X and Y for each other with no changes in the level of expression of either protein. B and C, Increased protein level of either, but not both, X or Y. D, Increase in protein level of both X and Y. The affinity between X and Y could be altered in numerous ways, such as intramolecular conformational changes that unmask domains or modification by other module members not considered in this binary model. Furthermore, there are various means by which the ratio of X to Y may change, for instance, transcriptional or translational regulation, sequestration (or loss thereof), or interaction with activator or inhibitor proteins. The experimental design described herein was formulated to provide evidence supporting which of these four mechanisms are used by the myocardial signaling architecture to regulate PKC⑀ and Src interaction during cardioprotection. Src modules was disrupted by the same mechanism that blocked cardioprotection, ie, inhibition of PKC⑀. 7, 10 Together, these findings suggest that the formation of PKC⑀-Src modules in response to NO is a mechanism by which the heart carries out cardioprotective signaling.
Discussion
To our knowledge, this is the first study to demonstrate that the assembly of a signaling module is a means for cardiac cell signaling, and that the formation of signaling modules containing PKC⑀ and Src is an essential step in NO-induced cardioprotection. There are a number of salient observations in this study. In the in vitro setting, our data demonstrate that PKC⑀ interacts with Src, and that this interaction promotes the activation of Src. In cardiac cells and in the normal myocardium, our results show that formation of PKC⑀-Src modules serves to accomplish signal transduction. In addition, the formation of PKC⑀-Src modules is subcellular compartment-dependent, in that it only occurs in the particulate fraction. Finally, and of particular importance, we found that administration of an NO-donor promotes PKC⑀-Src module formation during the development of cardioprotection in conscious rabbits. In NO-induced PC, the configuration of this module facilitates signal transduction by increasing PKC⑀-associated Src kinase activity. Inhibition of PKC with CHE, at a dose that has previously been demonstrated to block NOinduced cardioprotection, 7, 10 was sufficient to abolish PKC⑀-Src module formation and PKC⑀-associated Src activity.
Module Formation as a Means for Signal Transduction
Recent advances in molecular technologies have allowed for the identification of molecules that participate in biochemical responses. However, the precise manner in which these molecules interact to transmit subcellular signals is unclear.
Studies regarding signaling paradigms in noncardiac tissues have identified the assembly of signaling complexes as a means for signal transduction. [13] [14] [15] [16] Moreover, our laboratory has conducted an extensive characterization of the PKC⑀ signaling complex in the murine myocardium and found that Src (along with Ϸ35 other proteins) is a member of this complex. 17 In concert with these findings, we have proposed the "signaling module hypothesis" of PKC⑀, 36 in which we suggest that the formation of stimulus-and subcellular location-specific signaling modules may be a mechanism whereby a multiprotein complex coordinates signal transduction. 36 In the present study, we undertook the characterization of a module containing a serine/threonine kinase, PKC⑀, and a tyrosine kinase, Src. Our data show that the formation of this module enhanced PKC⑀-associated Src activity, indicating that the interaction of these two kinases promotes signal transduction. Molecular analyses of Src reveal that both the SH2 and the SH3 domains contain multiple PKC phosphorylation motifs (a.a. S/T-X-K/R). Several investigations have shown that the SH2 and SH3 domains are the preferred regions for interaction of Src tyrosine kinase with other proteins, including the epidermal growth factor receptors, 37 the ␤ 3 -adrenergic receptors, 14 and the receptors for activated C kinases. 27 To our knowledge, the present study represents the first demonstration that PKC⑀ can directly interact with Src and that this interaction is sufficient to lead to the activation of Src.
NO-Induced Cardioprotection Requires PKC⑀-Src Module Formation
To determine whether the assembly of multiprotein complexes serves as a means for cardioprotective signal transduction, we characterized the formation of PKC⑀-Src modules during the genesis of NO-induced PC. We found that NOinduced late PC involves an increase in module formation between PKC⑀ and Src. This increase in association was accompanied by a dramatic (10-fold) enhancement of PKC⑀-associated Src kinase activity only in the particulate fraction of the cell, indicating that the association of Src with the PKC⑀ signaling complex is a subcellular location-specific occurrence. It was also found that the PKC inhibitor CHE, given at a dose shown previously to abrogate the infarct-and stunning-sparing effects of NO-induced PC, was sufficient to block the increased PKC⑀-Src module formation afforded by NO. In addition, this dose of CHE also attenuated the increase in PKC⑀-associated Src activity that was seen 30 minutes and 24 hours after NO treatment. To our knowledge, no previous study has identified the formation of signaling modules as a mechanism of accomplishing signal transduction in vivo. Furthermore, the findings suggest that the formation of signaling complexes is not a random association of proteins or an artifact of immunoprecipitation procedures. Rather, the fact that association with PKC⑀ enhances Src enzymatic activity suggests that the formation of these modules is a highly organized event that facilitates the transmission of a subcellular signal. In view of the fact that both PKC⑀ and Src have been shown to play necessary roles in NO-induced PC, 7, 34 the data herein indicate that PKC⑀-Src modules direct signal transduction in NO-induced cardioprotection.
While it has been shown that PKC⑀ associates with a large number of other proteins within a signaling complex, it is rational to hypothesize that not all of the proteins within the PKC⑀ complex participate in all of the physiological processes that involve PKC⑀. Accordingly, we propose that signaling complexes, like the PKC⑀ complex characterized by our laboratory, 17 which contain within them stimulusresponsive and subcellular location-specific modules, like the PKC⑀-Src module that is described herein, may represent a means by which the cell uses multifunctional signaling elements to perform distinct subcellular tasks. 36 For example, the PKC⑀-Src signaling module is cardioprotective, whereas a different subset of proteins within the PKC⑀ complex containing connexin43, that would constitute a distinct module, may interact to coordinate excitation-contraction coupling. 38 
Molecular Mechanisms Underlying Module Formation
To elucidate the molecular mechanisms responsible for increased module formation, we characterized the expression levels of PKC⑀ and Src, as well as the nature of the affinity of these two molecules for each other. In these studies, we found that NO induced an increase in the particulate PKC⑀ protein at 30 minutes and at 24 hours, with no change in particulate Src protein at either of these time points (Figure 2 ). These data indicate that one of the mechanisms leading to increased complex formation between PKC⑀ and Src is an increase in the ratio of PKC⑀ protein to Src protein relative to basal conditions ( Figure 3) . Furthermore, we found that PKC⑀ and Src interactions only existed in the particulate fraction where Src has been reported to be in its open configuration. 26 This evidence, combined with the in vitro finding that the open conformation of Src favors its interaction with PKC⑀ ( Figure 1C ), suggests that an altered affinity of Src for PKC⑀ may also contribute to the formation of PKC⑀-Src modules (Figure 3 ).
Conclusion
A challenge for the development of pharmacological strategies that target specific signaling events is the physiological ubiquity of many of the proteins involved in protective phenomena (ie, preconditioning). In addition to participating in cardioprotection, both PKC⑀ and Src tyrosine kinase are also involved in numerous other signaling events across a variety of cell types. An essential step toward addressing this challenge is the characterization of the distinct manner in which proteins interact to define a module. This information would provide a level of specificity that could not be achieved solely from the biochemical properties of the individual molecules. Thus, rather than to activate a single molecule, which would impact multiple signaling events, future pharmacological and/or genetic interventions may be tailored to specifically recapitulate the endogenous interactions that constitute a protective module.
